Answer
Patients with PNH receiving Fabhalta (iptacopan) should be monitored regularly for signs and symptoms of haemolysis, including measurement of lactate dehydrogenase (LDH) levels.
Sources for this answer
- FABHALTA 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked